Medical groups sue to halt CDC vaccine advisory meeting and new child immunization guidelines under Health Secretary RFK Jr. Read more here.

Context for Novavax after recent share performance Novavax (NVAX) has drawn fresh attention after a recent move in its share price, with the stock showing a 3.3% one day return alongside gains over ...

Experts say ‘they’re just coming up with reasons’ as agency says application lacked ‘adequate and well controlled’ trial ...

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...

Novavax (NVAX) closed at $8.97 in the latest trading session, marking a +2.51% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 0.01%. Meanwhile, the Dow ...

Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.

Articles about Rebecca Klapper ...

TAMPA, Fla. — Florida’s Department of Health is meeting in Panama City Beach on Friday to discuss potential changes to the state’s vaccine requirements, a proposal that could significantly alter which ...

SHILLINGTON, Pa. – The Centers for Disease Control and Prevention says it's reducing the number of vaccines it routinely recommends for all children. However, Pennsylvania is standing firm.

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two ...

On Feb. 10, pharmaceutical company Moderna announced that the FDA Center for Biologics Evaluation and Research (CBER) had refused to review its application to market an investigational mRNA-based flu ...